Impact of Direct-Acting Antivirals on Insulin Resistance and Hepatic Steatosis in Treatment-Naïve Chronic HCV-Infected Nondiabetic Patients: A Prospective Study from North India

Conference Reports for NATAP

The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025


Impact of Direct-Acting Antivirals on Insulin Resistance and Hepatic Steatosis in Treatment-Naïve Chronic HCV-Infected Nondiabetic Patients: A Prospective Study from North India

	AASLD 2026 Denver